This could translate to visibly fuller hair and reduced thinning over time
Last reviewed: June 4, 2026 Last updated: June 4, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
The clinician conversation matters more, not less
Market dynamics: Manufacturer pricing decisions, the entry of generic or biosimilar GLP-1 products, and changes in insurance coverage could all affect the demand for compounded GLP-1 medications and the economic viability of compounding pharmacies in this space
Market Definition The GLP-1 receptor agonist market includes the research, development, production, and commercialization of glucagon-like peptide-1 (GLP-1) receptor agonist drugs
The medications make these changes easier to maintain